Bausch Short Long Term Debt vs Property Plant Equipment Analysis
BHC Stock | USD 8.71 0.09 1.04% |
Bausch Health financial indicator trend analysis is way more than just evaluating Bausch Health Companies prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Bausch Health Companies is a good investment. Please check the relationship between Bausch Health Short Long Term Debt and its Property Plant Equipment accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bausch Health Companies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate.
Short Long Term Debt vs Property Plant Equipment
Short Long Term Debt vs Property Plant Equipment Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Bausch Health Companies Short Long Term Debt account and Property Plant Equipment. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Bausch Health's Short Long Term Debt and Property Plant Equipment is 0.51. Overlapping area represents the amount of variation of Short Long Term Debt that can explain the historical movement of Property Plant Equipment in the same time period over historical financial statements of Bausch Health Companies, assuming nothing else is changed. The correlation between historical values of Bausch Health's Short Long Term Debt and Property Plant Equipment is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Short Long Term Debt of Bausch Health Companies are associated (or correlated) with its Property Plant Equipment. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Property Plant Equipment has no effect on the direction of Short Long Term Debt i.e., Bausch Health's Short Long Term Debt and Property Plant Equipment go up and down completely randomly.
Correlation Coefficient | 0.51 |
Relationship Direction | Positive |
Relationship Strength | Weak |
Short Long Term Debt
The total of a company’s short-term and long-term borrowings.Property Plant Equipment
Most indicators from Bausch Health's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Bausch Health Companies current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bausch Health Companies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. At present, Bausch Health's Tax Provision is projected to decrease significantly based on the last few years of reporting. The current year's Sales General And Administrative To Revenue is expected to grow to 0.31, whereas Issuance Of Capital Stock is forecasted to decline to 0.00.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 6.0B | 5.8B | 6.2B | 6.5B | Total Revenue | 8.4B | 8.1B | 8.8B | 9.2B |
Bausch Health fundamental ratios Correlations
Click cells to compare fundamentals
Bausch Health Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Bausch Health fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 33.9B | 31.2B | 29.2B | 25.7B | 27.4B | 14.9B | |
Short Long Term Debt Total | 25.9B | 23.9B | 22.7B | 20.8B | 22.4B | 23.5B | |
Other Current Liab | 2.1B | 4.6B | 4.8B | 3.0B | 1.0B | 1.2B | |
Total Current Liabilities | 6.2B | 4.9B | 5.2B | 3.9B | 4.3B | 4.5B | |
Total Stockholder Equity | 1.1B | 535M | (106M) | (692M) | (1.0B) | (970.9M) | |
Property Plant And Equipment Net | 1.5B | 1.6B | 1.6B | 1.6B | 1.7B | 1.8B | |
Net Debt | 22.7B | 23.3B | 22.1B | 20.2B | 21.4B | 22.5B | |
Retained Earnings | (7.5B) | (8.0B) | (9.0B) | (9.2B) | (9.8B) | (9.3B) | |
Accounts Payable | 503M | 337M | 407M | 521M | 719M | 755.0M | |
Cash | 3.2B | 605M | 582M | 564M | 947M | 502.7M | |
Non Current Assets Total | 26.9B | 25.9B | 23.6B | 21.4B | 21.8B | 12.7B | |
Non Currrent Assets Other | 411M | 664M | 340M | 326M | 307M | 236.2M | |
Cash And Short Term Investments | 3.2B | 605M | 582M | 564M | 947M | 506.0M | |
Net Receivables | 1.8B | 1.6B | 1.8B | 1.8B | 2.0B | 2.1B | |
Common Stock Shares Outstanding | 352.1M | 355M | 358.9M | 362M | 364.9M | 246.3M | |
Liabilities And Stockholders Equity | 33.9B | 31.2B | 29.2B | 25.7B | 27.4B | 14.9B | |
Non Current Liabilities Total | 26.5B | 25.7B | 24.0B | 21.5B | 23.1B | 24.3B | |
Other Current Assets | 779M | 855M | 720M | 776M | 1.1B | 1.1B | |
Other Stockholder Equity | 429M | 454M | 462M | 159M | 214M | 203.3M | |
Total Liab | 32.7B | 30.6B | 29.2B | 25.4B | 27.4B | 28.8B | |
Property Plant And Equipment Gross | 1.5B | 1.6B | 3.4B | 3.5B | 3.8B | 4.0B | |
Total Current Assets | 7.0B | 5.3B | 5.6B | 4.2B | 5.6B | 5.9B | |
Accumulated Other Comprehensive Income | (2.1B) | (2.1B) | (1.9B) | (2.1B) | (1.9B) | (1.8B) | |
Short Term Debt | 1.2B | 52M | 49.9M | 432M | 450M | 472.5M | |
Intangible Assets | 10.2B | 8.4B | 6.9B | 5.8B | 6.5B | 5.8B | |
Inventory | 1.1B | 1.1B | 993M | 1.1B | 1.5B | 1.6B | |
Common Stock Total Equity | 10.2B | 10.2B | 10.3B | 10.4B | 11.9B | 7.0B | |
Common Stock | 10.2B | 10.2B | 10.3B | 10.4B | 10.4B | 6.1B | |
Other Liab | 1.6B | 1.5B | 1.2B | 967M | 1.1B | 1.3B | |
Current Deferred Revenue | 2.4B | (52M) | (49.9M) | 2.1B | 2.4B | 2.5B | |
Other Assets | 1.8B | 2.8B | 2.3B | 2.3B | 2.6B | 2.7B | |
Long Term Debt | 24.7B | 23.9B | 22.7B | 20.3B | 21.9B | 14.0B | |
Good Will | 13.1B | 13.0B | 12.5B | 11.5B | 11.2B | 7.2B | |
Property Plant Equipment | 1.5B | 1.6B | 1.6B | 1.8B | 2.1B | 2.2B | |
Net Tangible Assets | (22.3B) | (21.0B) | (19.5B) | (18.0B) | (16.2B) | (17.0B) | |
Noncontrolling Interest In Consolidated Entity | 73M | 70M | 72M | 952M | 1.1B | 1.1B | |
Retained Earnings Total Equity | (7.5B) | (8.0B) | (9.0B) | (9.2B) | (8.3B) | (7.9B) | |
Long Term Debt Total | 24.7B | 23.9B | 22.7B | 20.3B | 23.4B | 21.5B |
Pair Trading with Bausch Health
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bausch Health position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bausch Health will appreciate offsetting losses from the drop in the long position's value.Moving together with Bausch Stock
0.73 | A | Agilent Technologies Financial Report 28th of May 2024 | PairCorr |
0.8 | ELEV | Elevation Oncology Earnings Call This Week | PairCorr |
0.7 | FHTX | Foghorn TherapeuticsInc Financial Report 13th of May 2024 | PairCorr |
Moving against Bausch Stock
0.51 | MOLN | Molecular Partners Financial Report 10th of May 2024 | PairCorr |
The ability to find closely correlated positions to Bausch Health could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bausch Health when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bausch Health - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bausch Health Companies to buy it.
The correlation of Bausch Health is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bausch Health moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bausch Health Companies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bausch Health can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bausch Health Companies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. Note that the Bausch Health Companies information on this page should be used as a complementary analysis to other Bausch Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Complementary Tools for Bausch Stock analysis
When running Bausch Health's price analysis, check to measure Bausch Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bausch Health is operating at the current time. Most of Bausch Health's value examination focuses on studying past and present price action to predict the probability of Bausch Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bausch Health's price. Additionally, you may evaluate how the addition of Bausch Health to your portfolios can decrease your overall portfolio volatility.
CEOs Directory Screen CEOs from public companies around the world | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Transaction History View history of all your transactions and understand their impact on performance | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |
Is Bausch Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bausch Health. If investors know Bausch will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bausch Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.115 | Earnings Share (1.62) | Revenue Per Share 23.998 | Quarterly Revenue Growth 0.098 | Return On Assets 0.0382 |
The market value of Bausch Health Companies is measured differently than its book value, which is the value of Bausch that is recorded on the company's balance sheet. Investors also form their own opinion of Bausch Health's value that differs from its market value or its book value, called intrinsic value, which is Bausch Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bausch Health's market value can be influenced by many factors that don't directly affect Bausch Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bausch Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bausch Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bausch Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.